U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519837) titled 'Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics' on March 18.
Brief Summary: Cancer cachexia is a complex systemic metabolic syndrome with high incidence and mortality rates, significantly impacting the prognosis and survival of cancer patients.Current clinical comprehensive intervention approaches can only provide transient symptom relief and fail to fundamentally block or reverse muscle and fat loss. The core challenge lies in the extreme complexity of this pathological mechanism and the lack of early biomarkers.To overcome the limitations of traditional single-dimensional research approa...